Christophe Weber is president, chief executive officer (CEO) and representative director of Takeda. He joined the company in April 2014 as chief operating officer, was named president and representative director in June 2014, and was subsequently appointed CEO in April 2015.

2 days ago · Takeda CEO Christophe Weber plans to retire next year after a decade steering the Japanese drugmaker, a tenure in which he led Takeda through one of the largest pharmaceutical mergers in history and a major research and development revamp. Julie Kim, currently president of the company’s U.S ...

1 day ago · Christophe Weber will step down as CEO of Takeda next year, the company announced Thursday, following a drop-off in its share price over the last couple of years. Weber, 59, has led the Japanese ...

1 day ago · Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S. business unit. As part of the executive transition, Weber will retire in June 2026 after 12 years at the drugmaker. Prior to joining the Japanese pharma giant, Weber worked at ...

2 days ago · CEO Christophe Weber to retire from Takeda in June 2026 after 12 years Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process “The Board of ...

1 day ago · Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Takeda ...

2 days ago · Mr. Weber will not hold a Board seat after retiring from Takeda. “The Board of Directors has unanimously chosen Julie Kim to lead Takeda into the next chapter, building on the company’s success under Christophe Weber’s remarkable leadership,” said Masami Iijima, chair of the Board of Directors meeting and of the Nomination Committee.

By Rocky Swift TOKYO (Reuters) -Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped ...

2 days ago · Tokyo, Jan. 30 (Jiji Press)--Japan's Takeda Pharmaceutical Co. said Thursday that its president and CEO, Christophe Weber, will step down at its general shareholders meeting in June 2026.

18 hours ago · After 12 years at the helm, Takeda CEO Christophe Weber will retire in June 2026. The company announced yesterday that its board of directors unanimously appointed Julie Kim, who is currently the president of the company’s U.S. business unit, as Weber’s successor. Kim will be the company’s first female CEO.